P&G to acquire Thorne in push to expand health business
Consumer appetite for wellness products has tilted toward supplements, pulling packaged-goods companies into a category that specialist brands have long held. Procter & Gamble is moving there directly. Chief executive Shailesh…
Key takeaways
- Procter & Gamble will acquire supplements brand Thorne to grow its health business, CEO Shailesh Jejurikar told CNBC's "Squawk on the Street."
- P&G, which has long anchored its revenues in household and personal care, sees the deal as a move into the recurring-purchase supplements category where consumer loyalty is high and price sensitivity is lower.
- The acquisition reflects a sector-wide cycle of portfolio premiumization, with large staples groups pushing beyond legacy categories in search of margin and growth.
- Jejurikar disclosed no deal terms on CNBC, leaving the financial structure of the acquisition undisclosed for now.
- The move is a bet that wellness spending is a structural trend, though discretionary wellness spending could face pressure if household incomes soften or private-label alternatives narrow the quality gap.
Consumer appetite for wellness products has tilted toward supplements, pulling packaged-goods companies into a category that specialist brands have long held. Procter & Gamble is moving there directly. Chief executive Shailesh Jejurikar told CNBC's "Squawk on the Street" that the company will acquire supplements brand Thorne, describing the deal as a play to grow P&G's health business.
A calculated move inside the health portfolio
Jejurikar's remarks on CNBC were plain: P&G sees health as a growth area, and Thorne fits that thesis as a supplements brand. P&G has anchored its revenues in household and personal care for decades. A supplements acquisition shifts the company toward a recurring-purchase category where consumer loyalty tends to run high and price sensitivity lower than in commodity household goods. That gap in the portfolio is what Thorne is meant to fill.
Where this sits in the sector-wide cycle
Sector-wide, consumer health has drawn sustained M&A attention as the demand environment for science-backed wellness brands has strengthened. Supplements occupy an intersection of retail pharmacy, direct-to-consumer, and e-commerce channels. For a company with P&G's distribution scale, adding Thorne offers reach into wellness-focused consumers who may not overlap with its core household base. The broader cycle here is one of portfolio premiumization: large staples groups pushing outside legacy categories in search of margin and growth.
The macro read-through and what to watch
The read-through for the staples sector is meaningful. Capital has rotated toward health and wellness within consumer goods as post-pandemic spending patterns have proved stickier than many expected. Cross-border demand for supplement brands with credentialed positioning has grown alongside that shift. On balance, P&G's acquisition of Thorne is a wager that the wellness spending trend is structural, not a passing cycle.
The macro caveat is the consumer itself. Discretionary wellness spending faces real pressure if household incomes soften or if private-label alternatives close the quality-perception gap. Jejurikar offered no deal terms on CNBC; the financial structure of the acquisition, when disclosed, will show how aggressively P&G priced the durability of the trend it is betting on.
Source · 來源